Assessment of the safety, tolerability, and PK/PD properties of two new formulations of subcutaneously administered IFN-beta1a: a double-blind, placebo-controlled comparison with the currently available formulation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples